相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。TRK fusion positive cancers: From first clinical data of a TRK inhibitor to future directions
Giandomenico Roviello et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application
Wei Yan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Revisiting NTRKs as an emerging oncogene in hematological malignancies
Sunil K. Joshi et al.
LEUKEMIA (2019)
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children
A. Drilon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Mechanisms of Resistance to NTRK Inhibitors and Therapeutic Strategies in NTRK1-Rearranged Cancers
Miho J. Fuse et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1)
Alexander Drilon et al.
CANCER DISCOVERY (2017)
A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion-Positive Solid Tumors
Alexander Drilon et al.
CANCER DISCOVERY (2017)
Fast-TRKing Drug Development for Rare Molecular Targets
Aparna R. Parikh et al.
CANCER DISCOVERY (2017)
Acquired Resistance to the TRK Inhibitor Entrectinib in Colorectal Cancer
Mariangela Russo et al.
CANCER DISCOVERY (2016)
NTRK gene fusions as novel targets of cancer therapy across multiple tumour types
Alessio Amatu et al.
ESMO OPEN (2016)
Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer
Anna F. Farago et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
(R)-2-Phenylpyrrolidine Substituted Imidazopyridazines: A New Class of Potent and Selective Pan-IRK Inhibitors
Ha-Soon Choi et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
TRKing Down an Old Oncogene in a New Era of Targeted Therapy
Aria Vaishnavi et al.
CANCER DISCOVERY (2015)
Trk signaling regulates neural precursor cell proliferation and differentiation during cortical development
Katarzyna Bartkowska et al.
DEVELOPMENT (2007)
TrkA alternative splicing: A regulated tumor-promoting switch in human neuroblastoma
A Tacconelli et al.
CANCER CELL (2004)
分享论文
